Neuro-Oncology News

Michael A. Caligiuri, MD, has been inaugurated as the 2017-2018 president of the American Association for Cancer Research.

The number of prescriptions written for physician-aided deaths in Oregon has increased annually since it became the first state to enact the Death with Dignity Act in 1997, according to a retrospective cohort study published in JAMA Oncology.

Sexual and gender minorities diagnosed with cancer may encounter specific challenges, including discrimination and greater risks for anxiety and depression, according to an ASCO guideline published in Journal of Clinical Oncology.

A wearable medical device designed to deliver alternating electrical fields administered in addition to temozolomide chemotherapy improved survival in patients with glioblastoma, according to results from the phase 3 EF-14 trial presented at the American Association for Cancer Research Annual Meeting.

International and private sector collaboration, as well as the $1.8 billion in federal funding directed toward the NIH as part of the 21st Century Cures Act, are two major accomplishments of the national cancer moonshot initiative achieved in the past year, according to former Vice President Joe Biden.

Overall cancer death rates continued to decrease in men, women and children among all racial and ethnic groups, according to the Annual Report to the Nation on the Status of Cancer.

Over the next 10 years, the number of cancer survivors in the United States is expected to grow from 15.5 million to 20.3 million, according to ASCO’s State of Cancer Care in America: 2017 report released today.

Many of the nation’s leading research organizations and cancer centers have voiced their opposition to President Donald J. Trump’s proposed budget, which includes a $5.8 billion cut to NIH funding in 2018.

Cancer researchers at Washington University School of Medicine in St. Louis have developed an online cancer database designed to streamline the sharing of tumor-related genetic information.

The Association of Community Cancer Centers’ Institute for Clinical Immuno-Oncology issued a white paper titled “Immuno-Oncology: There’s more to discover.”